Weighted Vests: The Science Behind Bone Density and Calorie Burn

Behind the Vest: A Definition Worth Reading

A weighted vest is a close-fitting torso garment that adds resistance through distributed front-and-back load. Standard trial protocols use 4–10% of bodyweight. The design keeps the load axial, centered over the spine rather than rear-shifted like a backpack. Original use cases were military and firefighter training, where load carriage is occupational.

The vest moved into clinical research through postmenopausal bone studies, most notably a foundational 5-year longitudinal trial on hip bone preservation. From there, it migrated into the wellness mainstream. It's commonly confused with weighted backpack walking ("rucking"), but the distinction matters: vest load is symmetric and axial, while ruck load is rear-shifted and alters spinal mechanics differently.

Marketing for weighted vests clusters around four outcomes:

• Preserves hip bone mineral density in midlife and beyond
• Increases calorie burn proportionally to added load during walking
• Improves cardiovascular fitness without running
• Supports postural and balance adaptations under load

The Biology of Loaded Walking

The primary mechanism is Frost's mechanostat. Bone tissue remodels when peak mechanical strain exceeds a threshold. Below that threshold, bone maintenance stalls. Weighted walking adds axial load to the skeleton; jumping and resistance training amplify peak strain further. A 2025 mechanostat reverse-engineering study in mice confirmed that strain magnitude, not movement frequency, drives the adaptive signal.

Secondary mechanisms add to the picture. Load-carriage exercise increases calcium absorption and retention beyond what mechanical loading alone would predict, meaning the skeleton's mineral supply may also shifts under vest use. Energy expenditure rises proportionally to added mass during walking, making the calorie-burn claim mechanically straightforward. And balance and proprioceptive indices improve under structured weighted-vest exercise in older women, likely through neuromuscular adaptation to the altered load environment.

What's less clear is the dose-response curve. Simply increasing resistance during jump exercise did not enhance cortical bone formation in animal models. More weight does not translate to proportional bone benefit. The optimal combination of vest load, exercise frequency, and population characteristics is still being mapped.

The Specs That Actually Matter

Spec literacy determines whether the vest you're looking at can actually deliver the load distribution used in research. Brand names matter less than spec floors.

• Total load. Research-supported range is 4–10% of bodyweight, per the protocols used in the foundational 5-year postmenopausal trial and a 2024 follow-up. The mechanostat responds to peak strain magnitude. Chronic underload doesn't cross the remodeling threshold. Fixed-load consumer vests below 4% bodyweight are a red flag for adults at average load tolerance.
• Load distribution. Research-supported pattern is symmetric front-and-back loading. Asymmetric rear-only load shifts spinal mechanics toward rucking, not the vest-bone literature. Pure-rear-load vests are the red flag here.
• Adjustability. Trial protocols escalate load progressively over months, typically in 1–2 lb increments. Fixed-load vests at a single weight cap the ability to follow the dose-response curve the evidence actually tested.
• Fit and chafe pattern. A close-torso fit with no shoulder slip is the research-supported standard. Shoulder slip transfers load to cervical and shoulder structures, inter-limb asymmetries under load can be exacerbated by poor vest fit. Loose-fit consumer vests are the red flag for deconditioned users.

Three tiers cover most of the market. Entry-tier consumer vests typically ship at fixed loads under 20 lb without micro-adjustment. Mid-tier vests offer 1–2 lb increments up to 40–50 lb. Clinical or premium vests offer balanced front-and-back loading with 0.5–1 lb increments and shoulder padding designed for older-adult use. No single brand earns a top pick here. The tier names are heuristics, and what matters is whether the spec floor matches the loads used in the foundational 5-year postmenopausal trial and the 2024 vest-plus-protein follow-up.

Entry-tier limits dose escalation and is unlikely to match trial protocols for most adults. Mid-tier matches trial protocols for healthy adults. Clinical or premium matches trial protocols for older adults and frail populations where fit precision and load control matter most.

Grading the Weighted Vest Claims

If you're evaluating a vest, the marketed claims span hip bone mineral density in postmenopausal women, calorie burn proportional to added load, cardiovascular fitness, and balance or fall-risk reduction in older adults.

Preserves hip bone mineral density in postmenopausal women: Moderate

A 5-year longitudinal trial showed that vest plus jumping preserved hip bone density in postmenopausal women across 32 weeks of training per year. A 2024 follow-up extended this to vest plus protein supplementation, showing delayed muscle and bone loss in older female adults. The evidence base is narrow: postmenopausal women in structured programs, and it does not extend to weighted walking alone. One relevant readout is DEXA T-score at the hip, retested at 12–24 months.

Increases calorie burn proportionally to added load during walking: Strong

A 2024 metabolic-cost study directly measured the energy cost of walking with weighted vests at multiple loads and grades, confirming proportional energy expenditure with added mass. The caloric increases are real but modest in absolute terms. Marketing estimates tend to run high. This is the cleanest "device worked" readout because it's mechanically determined, not dependent on biological adaptation timelines.

Improves cardiovascular fitness without running: Limited

There is a modest VO2max signal in older-adult populations doing weighted-walking-plus-resistance programs. No head-to-head trial versus zone 2 running exists in healthy adults. The LIFTMOR trial illustrates what high-magnitude loading achieves for bone, and weighted walking sits at a lower stimulus profile than that. The relevant readouts are VO2max and resting HR at 8–12 weeks.

Supports balance and fall-risk reduction in older adults: Limited

A weighted-vest exercise trial in older women showed improvements in fall-risk indices. The sample was small and the context was a structured program, not casual vest walking. IMU signal attenuation per step under load adds biomechanical nuance: gait quality under load is not uniform across individuals, and the balance adaptation signal depends heavily on baseline neuromuscular status.

Where Weighted Vests Plausibly Earn Their Place

Bone mineral density, calorie burn, and balance each respond to a different vest load, so matching the load to the goal matters more than the product itself.

Hip bone density preservation in postmenopausal women. Moderate evidence from the foundational 5-year postmenopausal trial and a 2024 vest-plus-protein follow-up supports hip-density preservation when vests are paired with jumping or resistance training. The readout is DEXA T-score at 12–24 months, not how the hips feel.

Calorie-burn augmentation during regular walking. Strong evidence from a 2024 metabolic-cost study confirms proportional energy-expenditure increases with added vest mass. The readout is weight trajectory over time, plus resting HR or VO2max if cardiovascular adaptation is part of the goal.

Use during caloric restriction in older adults. A weight-loss trial in older adults with obesity showed that vest use attenuated bone loss during dietary weight loss. This is a specific and underappreciated use case. The readout is DEXA plus body composition at 12–24 months.

Where the vest is not the best tool. For full cardiovascular adaptation, the evidence sits with running or zone 2 cycling, not weighted walking. For bone density in diagnosed osteoporosis, first-line care typically involves a clinician-led plan; weighted walking is not a substitute, as demonstrated in the LIFTMOR literature. Standalone weighted walking is not a substitute for either.

A Protocol That Tracks the Evidence

These are not recommendations. Individual response varies. Any new weighted training should be discussed with a clinician if there is diagnosed bone disease, joint replacement, balance impairment, or use of medications affecting bone or fall risk.

1. Set your baseline. Discuss DEXA T-score (imaging, ordered by a clinician) plus 25-OH vitamin D, calcium, PTH, and IGF-1 with your provider. Add a resting-HR and VO2max snapshot. Log joint comfort, gait quality, and training load for 7 days before starting.
2. Match the trial dose. The foundational 5-year postmenopausal trial and a 2024 vest-plus-protein follow-up used vests at 4–10% of bodyweight, 3 times per week, paired with jumping or resistance training, not standalone walking.
3. Pick your retest interval before you start. DEXA: 12–24 months. Resting HR and ApoB: 8–12 weeks. VO2max: 12 weeks minimum. Setting the interval before starting prevents cherry-picking.
4. Track daily, review weekly. Adherence checkboxes plus one subjective rating (joint comfort, gait quality) plus one wearable metric (resting HR or daily step quality) keeps the signal-to-noise ratio manageable.
5. Retest at the end, and back off at the signals the literature documents. Use the same Day-0 markers, same lab, same morning protocol. Back-off triggers: new knee or hip pain that worsens with vest use; new shoulder or cervical loading symptoms; gait asymmetry; any change in balance.

Who a Weighted Vest Suits. And Who Should Skip

You're most likely to benefit from a weighted vest if you're a generally healthy adult, particularly a postmenopausal woman with no diagnosed osteoporosis or joint replacement, willing to pair vest use with jumping or resistance training. It's also a reasonable tool for someone looking to augment calorie burn during regular walking without changing the activity itself.

The contraindications are real and worth naming directly:

• Pregnancy: do not start or continue vest training without obstetric clearance. The biomechanical and cardiovascular demands of added load during pregnancy require direct clinical sign-off.
• Diagnosed osteoporosis: clinician sign-off is required before starting. LIFTMOR-style supervised resistance training is the better-evidenced pathway for this population, not self-directed weighted walking.
• Joint replacement or orthopedic compromise of the knees, hips, or lower back: vest use increases tibiofemoral stress, especially with suboptimal mechanics.
• Balance impairment in older adults: vest use under poor balance amplifies fall risk rather than driving balance adaptation.
• Deconditioned users at risk of gait alteration or cervical and shoulder loading: start under supervision, not independently.

If any of this applies, the right next step is a clinician, not a different brand of the same vest.

Safety, Joint Load, and the FDA Question

Vest use measurably increases knee load and tibiofemoral stress, particularly when mechanics are poor or fatigued. Inter-limb lean tissue asymmetries can be exacerbated under load, making fit and symmetry more consequential than they appear at rest. Cervical and shoulder loading is the most common discomfort pathway when vest fit is loose or shoulder slip occurs.

For users on antihypertensives or other medications that affect orthostatic response, monitoring resting HR and standing blood pressure during early sessions is prudent. For users on prescribed osteoporosis medication, vest use is adjunctive, not a replacement; coordinate with the prescribing clinician. Any recent lower-extremity injury without orthopedic clearance is a skip, not a modification.

The Markers That Show If a Vest Worked

You can't tell if your vest is working from how you feel. You can tell from a comparable Day 0 / Day N panel. Where N is the retest interval appropriate for the marker, not the device.

• DEXA T-score: Imaging, not bloodwork. The gold-standard measure of hip bone density; bone remodels slowly, so retest at 12–24 months is the minimum meaningful interval.
• 25-OH vitamin D: Bone-mineralization co-factor; sufficient vitamin D status is a precondition for any loading-based bone signal to register on DEXA. Retest at 8–12 weeks after any supplementation change.
• Calcium + PTH: Calcium-phosphate axis status; elevated PTH can suppress bone density on DEXA independent of loading, masking any vest-driven benefit.
• IGF-1: Anabolic-axis marker; a baseline before and after a 12-week loading program adds interpretive context to the DEXA result.
• Resting HR + VO2max: The cardiovascular readouts for vest-plus-walking adaptation; retest at 8–12 weeks for resting HR, 12 weeks minimum for VO2max.

If the markers move in the direction the mechanostat predicts, the vest may have contributed. If they don't, that's information too, and it doesn't mean the device is useless, only that the protocol as currently structured (load, frequency, paired modality) isn't moving the outcome that mattered. Adjust the input before abandoning the experiment.

Reading the Retest

Subjective markers (feeling stronger, perceived gait quality, easier stair climbing) are useful as daily adherence checks. They are not outcome measures. They're also biased toward whichever protocol the user is already invested in, which makes them unreliable as the primary signal.

Objective markers have their own timing constraints. DEXA retest cadence is 12–24 months. Anything sooner falls within the scanner's precision error and produces noise, not signal. Resting HR is sensitive at 8–12 weeks. VO2max requires at least 12 weeks of consistent training before a meaningful shift is detectable.

Meaningful change has a threshold. On DEXA, shifts below 0.5% are typically within precision error, but each DEXA site has their own specific change threshold. A 3–5 bpm drop in resting HR at 8–12 weeks is plausibly real if measured at the same time of day under the same conditions. Don't anchor on the one marker that moved while ignoring the ones that didn't. The full panel tells the story.

When Loading Becomes a Medical Question

If the reason someone is reaching for a weighted vest is suspected osteoporosis, persistent joint pain, new exertion intolerance, or a change in balance, that's a clinical evaluation, not a vest purchase. The appropriate pathway for DEXA-confirmed osteoporosis runs through endocrinology or rheumatology, not self-directed load escalation. Joint pain with loading belongs in orthopedics or primary care before it belongs in a training protocol.

Measuring the biology a vest is supposed to change (before buying, then after using) is the foundation of Superpower's approach to preventive health. The vest is the experiment; DEXA and the bloodwork are the readout.